Inhibikase TherapeuticsIKT
13F holders, Q4 2025 (December 31)74holders +20
16new positions
1sold out
2famous investors
$2.05avg. 13F price*
At the end of Q4 2025, 74 institutions reported holding Inhibikase Therapeutics Inc. (IKT) in their 13F filings, up 20 from Q3 2025. 16 opened new positions and 1 sold out. The largest holders were Sands Capital Alternatives, LLC ($26.7M), Soleus Capital Management, L.P. ($22.3M) and Fairmount Funds Management LLC ($17.7M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Inhibikase Therapeutics Inc.
- CUSIP
- 45719W205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $28.5M |
| Exits | 1 | $139 |
All 13F filers, Q3 2025 → Q4 2025: 35,420,246 shares bought and 238,076 shares sold, net +35,182,170 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 74 holders
| Sands Capital Alternatives, LLC | 5.15% | Add +18.9% | 13,018,965 | $26.7M |
| Soleus Capital Management, L.P. | 0.95% | Add +71.9% | 10,875,000 | $22.3M |
| Fairmount Funds Management LLC | 1.35% | Add +40.8% | 8,625,000 | $17.7M |
| ADAR1 Capital Management, LLC | 1.24% | Add +53.7% | 8,063,949 | $16.5M |
| Trails Edge Capital Partners, LP | 3.13% | — | 6,178,124 | $12.7M |
| Blackstone Inc. | 0.05% | Add +125.1% | 5,938,276 | $12.2M |
| Siren, L.L.C. | 0.36% | New | 5,850,000 | $12.0M |
| Perceptive Advisors LLC | 0.20% | No change | 5,421,568 | $11.1M |
| Commodore Capital LP | 0.74% | No change | 5,397,488 | $11.1M |
| Vanguard Group Inc. | 0.00% | Add +39.3% | 4,558,604 | $9.3M |
| Squadron Capital Management LLC | 3.87% | — | 4,225,000 | $8.7M |
| Nantahala Capital Management, LLC | 0.48% | Add +79.4% | 3,929,292 | $8.1M |
| Saturn V Capital Management LP | 1.45% | New | 3,856,799 | $7.9M |
| Spruce Street Capital LP | 2.43% | — | 3,581,603 | $7.3M |
| BlackRock, Inc. | 0.00% | Add +7.5% | 3,305,574 | $6.8M |
| Stonepine Capital Management, LLC | 3.81% | Add +219.5% | 2,348,147 | $4.8M |
| Kalehua Capital Management LLC | 3.55% | — | 1,750,000 | $3.6M |
| Integral Health Asset Management, LLC | 0.18% | New | 1,750,000 | $3.6M |
| Ameriprise Financial Inc. | 0.00% | New | 1,376,395 | $2.8M |
| Citadel Advisors | 0.00% | Add +1635.2% | 1,243,630 | $2.5M |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 1,128,239 | $2.3M |
| Exome Asset Management LLC | 0.61% | New | 600,000 | $1.2M |
| State Street Corp. | 0.00% | Add +9.3% | 554,849 | $1.1M |
| Seven Fleet Capital Management LP | 0.74% | — | 533,648 | $1.1M |
| Northern Trust Corp. | 0.00% | Reduce -13.8% | 322,720 | $662K |
| Millennium Management | 0.00% | New | 169,850 | $348K |
| Blair William & Co. | 0.00% | No change | 152,953 | $314K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 152,298 | $312K |
| Bank of New York Mellon Corp | 0.00% | Reduce -0.8% | 137,485 | $282K |
| Jane Street Group, LLC | 0.00% | New | 116,003 | $238K |
| Barclays PLC | 0.00% | Add +10.8% | 94,795 | $194K |
| UBS Group AG | 0.00% | Reduce -30.6% | 94,545 | $194K |
| Persistent Asset Partners Ltd | 0.09% | New | 93,430 | $192K |
| Goldman Sachs Group Inc. | 0.00% | Add +694.3% | 85,267 | $175K |
| Morgan Stanley | 0.00% | Add +42.2% | 79,682 | $163K |
| Nuveen, LLC | 0.00% | No change | 78,659 | $161K |
| Wells Fargo & Company | 0.00% | Add +48.3% | 67,833 | $139K |
| FMR LLC | 0.00% | Reduce -45.8% | 57,374 | $118K |
| Deutsche Bank AG | 0.00% | Reduce -31.8% | 54,909 | $113K |
| New York State Common Retirement Fund | 0.00% | No change | 47,900 | $98K |
| Rhumbline Advisers | 0.00% | Reduce -18.1% | 47,163 | $97K |
| Bank of America Corp. | 0.00% | Add +171.4% | 46,411 | $95K |
| Invesco Ltd. | 0.00% | Reduce -2.3% | 32,262 | $66K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 30,606 | $63K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +3.3% | 28,875 | $59K |
| Caxton Corp. | 1.36% | Add +73.6% | 28,453 | $58K |
| Intech Investment Management LLC | 0.00% | Reduce -15.8% | 26,884 | $55K |
| JPMorgan Chase & Co. | 0.00% | Reduce -50.2% | 24,849 | $51K |
| Virtu Financial LLC | 0.00% | Add +70.1% | 22,869 | $47K |
| Susquehanna International Group, LLP | 0.00% | Reduce -52.8% | 21,532 | $44K |
| XTX Topco Ltd | 0.00% | New | 20,298 | $42K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 17,638 | $36K |
| Scientech Research LLC | 0.02% | New | 15,977 | $33K |
| Voya Investment Management LLC | 0.00% | No change | 13,146 | $27K |
| BNP Paribas Financial Markets | 0.00% | Reduce -17.6% | 12,891 | $26K |
| Sanctuary Advisors, LLC | 0.00% | New | 12,539 | $26K |
| Victory Capital Management Inc. | 0.00% | New | 11,400 | $23K |
| ProShare Advisors LLC | 0.00% | Add +6.8% | 11,046 | $23K |
| Russell Investments Group, Ltd. | 0.00% | Add +40.4% | 10,814 | $22K |
| Focus Partners Advisor Solutions, LLC | 0.00% | Add +0.1% | 10,719 | $22K |
| HRT Financial LP | 0.00% | New | 10,570 | $21K |
| Royal Bank of Canada | 0.00% | Add +903.5% | 6,653 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -7.6% | 6,509 | $13K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 6,174 | $13K |
| Legal & General Group Plc | 0.00% | No change | 5,504 | $11K |
| Pinnacle Wealth Planning Services, Inc. | 0.00% | New | 5,400 | $11K |
| California State Teachers Retirement System | 0.00% | Reduce -1.6% | 3,715 | $8K |
| Citigroup Inc. | 0.00% | Add +264.3% | 3,286 | $7K |
| Sterling Capital Management LLC | 0.00% | Reduce -15.9% | 3,220 | $7K |
| Amalgamated Bank | 0.00% | Reduce -8.0% | 1,900 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | Add +12.2% | 101 | $207 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 4 | $8 |
| Allworth Financial LP | 0.00% | New | 1 | $3 |
| Cwm, LLC | 0.00% | Add +284.2% | 73 | $0 |
"% of holder's portfolio" is IKT's weight in each manager's 13F, not the share of Inhibikase Therapeutics Inc. the manager owns.